Nov 27, 2024
In this episode, host Shikha Jain, MD, speaks
with Michel van Harten, MD, about creating better
information systems for physicians and patients, how shared
decision-making can improve drug development and more.
• Welcome to another exciting episode of Oncology
Overdrive 0:14
• About van Harten 0:20
• The interview 1:00
• What was your journey to becoming a physician and
beyond to where you are now? 1:24
• How did you learn the necessary skills to be an
exceptional leader in this space?
2:51
• How many years were you a practicing physician for?
3:53
• What does myTomorrows do, and what drew you to this
type of work? 4:54
• Where is this service available?
7:19
• Jain and van Harten on the challenges patients face
surrounding eligibility for clinical trials.
8:36
• Where do you see this going down the line?
10:05
• Has your company looked into how to these services
can impact diversifying clinical trial enrollment?
12:04
• What are some challenges your company has faced?
13:50
• How quickly do you think growth will accelerate in
this space? 15:26
• How will this work and resource have major impacts
on drug development in a more accelerated way than in the past?
16:11
• From the patient-facing side, have you faced any
challenges concerning patients’ willingness to be enrolled in
clinical trials? 18:22
• What is next for you, and where do you see yourself
in twenty years? 19:13
• Do you have any concerns about AI in health care?
[…] What should we be aware of when utilizing AI in this space?
19:45
• Jain and van Harten on the challenges and setbacks
that come from outdated and inaccurate clinical trial databases.
21:35
• If someone could only listen to the last few minutes
of this episode, what would you want listeners to take away?
23:50
• How to contact van Harten
24:28
• Thanks for listening
25:17
Michel van Harten, MD, is the CEO of
myTomorrows.
We’d love to hear from you! Send your comments/questions to Dr. Jain at oncologyoverdrive@healio.com. Follow Healio on X and LinkedIn: @HemOncToday and https://www.linkedin.com/company/hemonctoday/. Follow Dr. Jain on X: @ShikhaJainMD. Michel van Harten can be reached via email michel.vanharten@mytomorrows.com.
Disclosures: Jain and van Harten report no relevant financial disclosures.